Home » Archive

Xconomy

News, Syndication, Xconomy »

West Coast Biotech Roundup: Onyx, Calico, Otonomy, Dendreon & More

Posted by sandiegobiotech August 14th, 2014 .
No Comments

[Corrected 8/14/14, 8:11pm. See below.] When Amgen (NASDAQ: AMGN) bought South San Francisco-based Onyx Pharmaceuticals last year for $10.4 billion, it expected great things from Onyx’s…

[[Click headline to continue reading.]]

More...

News, Syndication, Xconomy »

Otonomy Hears Wall Street Ovation as Some Life Sciences IPOs Dim

Posted by sandiegobiotech August 13th, 2014 .
No Comments

Auris Medical, the Swiss biotech focused on diseases and disorders of the ear, got the catchy ticker symbol (NASDAQ: EARS) when it went public last week. But San Diego’s Otonomy (NASDAQ: OTIC)…

[[Click headline to continue reading.]]

More...

News, Syndication, Xconomy »

Organovo to Offer Preclinical Drug Tests Based on 3-D Liver Tissue

Posted by sandiegobiotech August 13th, 2014 .
No Comments

San Diego-based Organovo (NYSE: ONVO) says a three-dimensional sample of living human liver tissue created with its bio-printing technology was used successfully for the first time to predict that a…

[[Click headline to continue reading.]]

More...

News, Syndication, Xconomy »

While Protesters Rage Against Tech Giants, Biotech Drives Quietly By

Posted by sandiegobiotech August 12th, 2014 .
No Comments

Not long ago, biotech made a lot of people angry. Up until 2005 or so, the annual Biotechnology Industry Organization conference attracted large street protests, which in turn attracted cops in riot…

[[Click headline to continue reading.]]

More...

News, Syndication, Xconomy »

West Coast Biotech Roundup: MappBio, Juno, Zosano, and More

Posted by sandiegobiotech August 7th, 2014 .
No Comments

The IPO window is still open, sort of, but life sciences companies are not getting through unscathed. San Francisco-based Tobira Therapeutics and New York’s Microlin Bio postponed their offerings…

[[Click headline to continue reading.]]

More...

News, Syndication, Xconomy »

Military Strategies Being Used in the War on Cancer

Posted by sandiegobiotech August 4th, 2014 .
No Comments

Nearly everyone has heard of the War on Cancer, which was launched during the Nixon administration with the passage of the National Cancer Act of 1971. The goal of this legislation was to eradicate…

[[Click headline to continue reading.]]

More...

News, Syndication, Xconomy »

West Coast Biotech Roundup: Amgen Layoffs, Avalanche, Venter & More

Posted by sandiegobiotech July 31st, 2014 .
No Comments

Summer in Seattle is usually a joyous season, but with the big West Coast news this week, a gloom more typical of the city’s winter months settled over the biotech community. Amgen (NASDAQ:…

[[Click headline to continue reading.]]

More...

News, Syndication, Xconomy »

Venter Hires Google Translate Leader at Human Longevity Startup

Posted by sandiegobiotech July 30th, 2014 .
No Comments

Human Longevity, the San Diego startup founded by human genomics pioneer J. Craig Venter, says it has recruited Franz Och, a 42-year-old expert in machine learning and language translation, to…

[[Click headline to continue reading.]]

More...

News, Syndication, Xconomy »

Epic Sciences Raises $30M to Advance Cancer Diagnostics

Posted by sandiegobiotech July 30th, 2014 .
No Comments

It’s been about six years since San Diego’s Epic Sciences was founded to commercialize technology that Peter Kuhn and others developed at The Scripps Research Institute for detecting and analyzing…

[[Click headline to continue reading.]]

More...

News, Syndication, Xconomy »

To Solve Alzheimer’s Mystery, Better Biological Clues Sorely Needed

Posted by sandiegobiotech July 29th, 2014 .
No Comments

The other day, I found a video on the website of the Alzheimer’s Association, a nonprofit foundation. It was part of an HBO documentary series produced a few years ago by Maria Shriver to…

[[Click headline to continue reading.]]

More...